Jiang-Ting Chen
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Outbreaks Research
-
- Hepatitis Viruses Studies and Epidemiology
Papers in
-
- Hepatitis Viruses Studies and Epidemiology 4
-
- Influenza Virus Research Studies 4
- Co-authors
- Weidong Yin (5 shared papers)Xu Wang (2 shared papers)Qiang Gao (2 shared papers)Hong Gao (1 shared paper)Chuan Qin (1 shared paper)Junyu Wu (2 shared papers)Yan Liu (2 shared papers)Xiaomei Zhang (1 shared paper)
- Journals
- Vaccine (4 papers)Human Vaccines & Immunotherapeutics (2 papers)Clinical and Vaccine Immunology (1 paper)Journal of Medical Virology (1 paper)Antiviral Therapy (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Jiang-Ting Chen
10 papers receiving 310 citations
Peers
Comparison fields: 5 of 34
- Infectious Diseases 205
- Hepatology 42
- Epidemiology 63
- Cardiology and Cardiovascular Medicine 29
- Toxicology 5
Countries citing papers authored by Jiang-Ting Chen
This map shows the geographic impact of Jiang-Ting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang-Ting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang-Ting Chen more than expected).
Fields of papers citing papers by Jiang-Ting Chen
This network shows the impact of papers produced by Jiang-Ting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang-Ting Chen. The network helps show where Jiang-Ting Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiang-Ting Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 134 | |
| 2 | 2005 | 75 | |
| 3 | 2013 | 28 | |
| 4 | 2010 | 25 | |
| 5 | 2007 | 21 | |
| 6 | 2010 | 18 | |
| 7 | 2012 | 14 | |
| 8 | 2012 | 12 | |
| 9 | 2013 | 7 | |
| 10 | Evaluation on Different Immunization Schedules of Hepatitis A Vaccine Healive | 2003 | 4 |
| 11 | Research on Safety and Immunogenicity of Trivalent Split Influenza Vaccine | 2005 | 1 |
About Jiang-Ting Chen
Jiang-Ting Chen is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Cardiology and Cardiovascular Medicine and Nuclear Energy and Engineering, having authored 11 papers that have together received 339 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Infectious Diseases (205 citations), Hepatology (42 citations), Epidemiology (63 citations), Cardiology and Cardiovascular Medicine (29 citations) and Toxicology (5 citations). Jiang-Ting Chen has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Weidong Yin, Xu Wang, Qiang Gao, Hong Gao, Chuan Qin, Junyu Wu, Yan Liu, Xiaomei Zhang, Yan Liu and Qunying Mao. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, Clinical and Vaccine Immunology, Journal of Medical Virology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.